| Date Filed | Type | Description |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4/A
| Hirsch Andrew (President & CEO) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,675 shares
@ $7.01, valued at
$25.8k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Hirsch Andrew (President & CEO) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Exercised 12,500 options to buy
@ $0 |
|
| 04/12/2022 |
4
| Hirsch Andrew (President & CEO) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $8.4, valued at
$84k
|
|
| 02/23/2022 |
4
| Hirsch Andrew (President & CEO) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0 |
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/12/2020 |
4
| Hirsch Andrew (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 11,538 options to buy
@ $27.49, valued at
$317.2k
|
|
| 04/24/2020 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,927 shares
@ $45.91, valued at
$88.5k
Exercised 5,893 restricted stock units
@ $0 |
|
| 04/15/2020 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,599 shares
@ $40.64, valued at
$65k
Exercised 5,387 options to buy
@ $0 |
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| Hirsch Andrew (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 11,538 options to buy
@ $21.74, valued at
$250.8k
|
|
| 04/24/2019 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 17,678 restricted stock units
@ $0 |
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 4,555 shares
@ $52.82, valued at
$240.6k
Exercised 15,000 options to buy
@ $0 |
|
| 07/24/2018 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2018 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 33,000 options to buy
@ $77.7, valued at
$2.6M
Granted 8,250 restricted stock units
@ $0 |
|
| 05/31/2017 |
4
| Hirsch Andrew (Director) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 23,076 options to buy
@ $13.75, valued at
$317.3k
|
|
| 05/31/2017 |
3
| Hirsch Andrew (Director) has filed a Form 3 on Editas Medicine, Inc. |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/21/2016 |
4
| Hirsch Andrew (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 125,000 options to buy
@ $49.83, valued at
$6.2M
|
|
| 09/21/2016 |
3
| Hirsch Andrew (CFO) has filed a Form 3 on AGIOS PHARMACEUTICALS INC |